Página 21 - Melhores Oncologia oncologistas - TOP-656 médicos

Oncogynecologist

Dr. Lee Seung Eun is a highly experienced General Surgeon with 18+ years of experience in performing pediatric and GI tract surgeries. She is a member of various medical associations and has received several awards. She has published papers in the fields of gallbladder cancer and pediatric cholecystectomy.

Oncologist

Gynecologist. Oncogynecologist

Oncosurgeon, Head of Samsung Department of Urology

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

NUTRITION AND DIET SPECIALIST 

Ezgi Sevic graduated from Hacettepe University, Department of Nutrition and Dietetic as Honor Student. During her education, she conducted studies on “'The Effect of Hedonic Eating Behavior on Obesity', 'Total Parenteral Nutrition in Children' and 'The Relationship Between Insulin Resistance and Obesity'.” During her education, she took part in the field in studies on determining the nutritional status of the society. She worked as intern dietitian in Hospitals of Hacettepe University (Oncology Hospital, Adults Hospital, İhsan Doğramacı Child Hospital), Dışkapı Yıldırım Beyazıt Training and Research Hospital and many Community Health Centres. 
She worked in Izmir Private Ekol Hospital. She successfully completed the 'Bariatric Nutrition Course' and the 'Innovations in Obesity Course'. She has participated in many training and seminar programs in her field. 

Interests: Post- Metabolic and Bariatric Surgery Nutrition, the Nutrition in Chronicle Diseases, Nutrition in Individuals with Diabetes, Nutrition in Cancer, Nutrition in Congenital Metabolic Diseases, Food Intolerances, Body Weight Control, Child and Adolescent Nutrition, Nutrition in Old Age, Nutrition in Pregnancy and Lactation.

Dietit. Ezgi Sevic knows advanced English. 

Dr. Serap Kaya is a medical oncologist with a specialization in Medical Oncology from Kocaeli University Faculty of Medicine. She has worked at several leading hospitals, including Oltu State Hospital, Kocaeli State Hospital, Marmara University Pendik Training and Research Hospital, and Medistate Kavacik Hospital. Dr. Kaya has made important contributions to cancer care at these institutions.

She is known for her evidence-based approach and focus on patient outcomes. Dr. Kaya has managed many complex oncology cases. She holds accreditation from top Turkish medical faculties. Dr. Kaya is committed to improving oncology practice through ongoing professional development and clinical excellence.

Dr. Jumana Baryhe is a specialist in advanced aesthetic and hair restoration procedures. She performs Botox injections, non-surgical nose correction, FUE and DHI hair transplants, beard and eyebrow transplants, brow lifts, lip implants, and laser vaginal rejuvenation. Dr. Baryhe is known for her skill in minimally invasive techniques. Her patients report high satisfaction with their results.

Dr. Baryhe is dedicated to excellence in her field. She has completed hundreds of successful procedures. Her reputation is built on technical expertise and personalized care. She uses the latest methods and follows international standards in cosmetic medicine.

Interesses Médicos 

Infertilidade e Inseminação Intrauterina (IIU) 

Tratamento de FIV (Fertilização In Vitro) 

Cirurgias laparoscópicas ginecológicas 

Operações histeroscópicas 

Gravidez e parto vaginal-cesariana 

Endometriose e Adenomiose 

Cirurgia laparoscópica da endometriose 

Mioma uterino e cirurgia do mioma uterino 

Doenças das trompas de falópio e cirurgias 

Cistos ovarianos e operações laparoscópicas relacionadas 

Cirurgia de incontinência urinária 

Cirurgia estética ginecológica 

Cirurgia de prolapso uterino e pélvico 

Lesões cervicais pré-malignas e tratamentos

Educação 

Universidade de Ancara, Faculdade de Medicina (1999 - 2006) 

Hospital de Saúde e Pesquisa das Mulheres Dr. Zekai Tahir Burak em Ancara, Proficiência (2007 - 2012) 

Hospital de Formação e Pesquisa Kanuni Sultan Suleyman em Istambul, Assistente Prof. (2015 - 2017) 

Comissão Europeia de Cirurgia Laparoscópica Ginecológica Avançada, IRCAD Estrasburgo, França (2013) 

Hospital de Formação e Pesquisa Kanuni Sultan Suleyman em Istambul, Professor Associado (2017 - 2020) 

Comissão Europeia de Cirurgia de Endometriose, IRCAD Estrasburgo, França (2019) 

Experiência 

Hospital de Formação e Pesquisa Kanuni Sultan Suleyman em Istambul (2014 - 2020) 

Hospital Internacional Sisli Kolan em Istambul (2020 - 2021) 

Hospital Liv Ulus (2021 -) 

Associações 

Sociedade Turca de Medicina Reprodutiva 

Associação Ginecológica Turco-Alemã 

Associação Turca de Ginecologia e Obstetrícia 

Sociedade Europeia de Endoscopia Ginecológica 

Associação de Ginecologia Minimamente Invasiva 

Sociedade de Uroginecologia Minimamente Invasiva 

Associação Europeia de Uroginecologia

Casos Anteriores Consideráveis

Gestão laparoscópica de adenomioma cístico juvenil decidualizado imitando uma gravidez cornual. 

Gestão laparoscópica de endometrioma coexistindo com tumor dermoide em um único ovário apresentando-se como endometrioma atípico 

Um caso de síndrome de hemivagina obstruída e anomalia renal ipsilateral complicada com piometra: dicas e truques para hemi-histerectomia laparoscópica. 

Suspensão de Ligamento Úterosacro Extraperitoneal Modificada na Prevenção de Risco de Prolapso do Coto após Histerectomia Vaginal; Método dos 4 Grampos. 

Ressecção Laparoscópica de Cavidade Endometrial Cega para Útero de Robert. 

Excisão Laparoscópica de Gravidez Cicatricial e Reparação de Istmocele. 

Procedimento de Manchester combinado com sacrohisteropexia laparoscópica por tunelização retroperitoneal

Tratamento cirúrgico: todos os tipos de operações em urologia.

Gestão geral do serviço médico. Atendimento policlínico de pacientes. Participação em conselhos. "Segunda opinião" em casos difíceis, avaliação especializada de situações clínicas. Organização e realização de cursos de formação, workshops, webinars.

Técnicas que o médico domina:

Incisão transuretral da próstata (TUIP) e Incisão transuretral de formações da bexiga urinária (TOIP).

Enucleação prostática a laser, ressecção a laser de tumores da bexiga.

Vaporização a laser da glândula prostática.

Incisão a laser de estenoses uretrais

Lítotricia a laser de contato ureterais, pielo- e cistolitíase

Nefrolitotomia percutânea (mini)

Cirurgia intrarrenal retrógrada e anterógrada (RIRS e AIRS) Operação Boari.

Cirurgia plástica da uretra em caso de lesão ou estenose

Prostatectomia por acesso transvesical

Cistostomia - aberta e por trocarte

Nefrostomia

Nefrectomia radical (incluindo laparoscópica)

Sutura de ruptura do rim

Pielolitotomia

Ureterolitotomia

Cirurgia plástica pieloureteral (laparoscópica)

Remoção de cistos renais (Cistectomia) (laparoscópica)

Ureterocistoneostomia

Ureterocutaneostomia

Operações para rupturas intra-abdominais e retroperitoneais da bexiga urinária

Orquectomia

Epididimectomia

Operações de Bergmann e Winckelmann

Revisão dos órgãos do portão devido a lesões e doenças inflamatórias

Operação de Ivanisevich e Marmar para varicocele, circuncisão, nefrostomia percutânea, nefrolitotripsia

Punção de cistos renais

Medical Interests and Activities 

Gastrointestinal diseases 

Oncologic laparoscopic surgery 

Anorectal area diseases 

Urgent surgical cases (acute cholecystitis, divertikülit, ileus, pankreatit, appendicitis) 

Colon and rectum cancer 

Treatment of oncologic surgical cases with further laparoscopic and robotic surgery. 

Laparoscopic hernia surgery 

Esophagus and stomach cancer 

Selim anorectal diseases (hemorrhoidal disease, anal fissure), perianal fistula, pilonoidal sinus (hairless- non-surgical treatment)

Education and Experience 

İstanbul University Medical Faculty 1988 

University of Colorado Health Science Center – Intern Surgeon 

Isparta, Dedeçam Şehit Ramazan Karaca Health Center (1995-1996) 

İstanbul Surgery Hospital – American Hospital (2000-2001) 

Chief assistant Istanbul Medical Faculty, Department of General Surgery (2001-2008) 

World Congress on Peritonel Surface Malignancies (HIPEC course) Berlin, Germany (2012) 

USC Keck School of Medicine, Los Angeles, CA, USA (2006-2007) 

Assoc. Prof. M.D. , İstanbul Medical Faculty General Surgery (2008-2014) 

Da Vinci Robotic Intensive Course at IRCAD, Strasbourg, France (2011) 

Stony Brook Medicine Cadaver Training Event in Colon and Rectal Surgery, New York, USA (2016) (Instructor) 

Fellow of the European Board of Surgery- Emergency Surgery (FEBS EmSurg) Honorary Diploma (2017) 

Prof. M.D. , İstanbul Medical Faculty General Surgery (2014 -2017) 

İstanbul University Medical Faculty – General Surgery Master of Science 1996 

University of Southern California Medical Center, Department of General Surgery, Los Angeles, USA – February 2006 – February 2007

Liv Hospital

Memberships 

Turkish Society of Surgery 

National Endoscopic Laparoscopic Surgery Association 

Turkish Colon and Rectum Surgery Association 

National Trauma and Emergency Surgery Association 

Hepato-Pancreato-Bilier Surgery Association 

Istanbul Surgical Association 

Flebology Association 

ESTES (European Society of Trauma and Emergency Surgery) 

International Society of Surgery (ISS)

Prof. Jürgen Kiwit is a German neurosurgeon with over 25 years of experience. He is the Head of the Neurosurgery Department at Meoclinic Berlin and specializes in the treatment of spinal cord and brain tumors pathologies, blood circulation disorders, and paraplegia. He has trained in the UK and USA and is a member of various professional societies. His expertise includes glioma therapy, complicated brain aneurysms surgeries, anti-pain therapy, brain injuries differentiated therapy, and nervous system dysfunctions.

Dr. Elnur Sahibov is a licensed Radiation Oncologist with 8 years of medical training and clinical experience. He completed his undergraduate and specialization studies at Marmara University Faculty of Medicine. From 2012 to 2016, he focused on advanced radiation oncology techniques.

Dr. Sahibov is known for his expertise in cancer treatment. He has helped improve patient outcomes and uses evidence-based protocols. He is accredited by leading medical institutions and is dedicated to ongoing professional development in oncology.

Dr. Plamen Straikov is a highly experienced surgeon specializing in bariatric and metabolic surgery. He is Medical Director at Sachsenhausen Hospital and has extensive experience in revision surgery before bariatric/metabolic surgery. He has held honorary professorship roles at V. N. Karazin Kharkiv National University and Odessa National Medical University, and is a member of several medical organizations.

Dr. Kemal Raşa is a highly experienced General Surgeon specializing in Modern Thyroidology & Laparoscopic Surgery with 23 years of experience. He is affiliated with several medical associations and has published several papers in his field.